Trial Information

Summary: Hypercholesterolemia in South Asian Subjects

The Diabetes-Endocrinology Center of WNY at Millard Fillmore Hospital, under the direction of Dr. Paresh Dandona is conducting a new research study with the investigational medication Rosuvastatin. The primary purpose of this research study is to evaluate the safety and efficacy of the use of Rosuvastatin by South Asian subjects for the treatment of high cholesterol with that of Atorvastatin, a medication currently available and approved by the FDA. The length of this study is between 12 and 24 weeks.

All study related diagnostic testing and exams will be of no cost to you. Compensation for time and travel along with free parking will be provided.

If you are at least 18 years of age, South Asian (origin India, Pakistan, Bangladesh, or Sri Lanka) and have hypercholesterolemia (high blood cholesterol) please call Jackie at 887-5107 or Iris at 887-4486 for more information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:43:28 AM